|
2019 September |
Estudi de la interacció entre l’EGF i el seu receptor EGFR per a crear lligands modificats i fer terà pia dirigida contra el cáncer |
Laplana Terrades, Blanca
|
|
|
2017 September |
Estudi de l’activitat biològica de compostos organometà l•lics com agents antitumorals vehiculitzats amb anà legs de la Bombesina |
Romero Pérez, Inés
|
|
|
2022 September |
Fabricació de scaffolds per al cultiu cel·lular de cèl·lules canceroses per a la formació de tumoroids |
CornellĂ i Llorens, Gerard
|
|
|
2019 January |
Functional outcomes of immunotherapy induction treatment and transoral robotic surgery therapeutic approach for oropharyngeal squamous cell carcinoma: an intervention study based on a prospective cohort |
Garcia Belerda, Ainhoa
|
|
|
Generation of new cytotoxic human ribonuclease variants directed to the nucleus |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ruiz MartĂnez, Santiago
; Tubert Juhé, Pere
; Escribano, Diego
; RibĂł i Panosa, Marc
; Vilanova i Brugués, Maria
; Benito i Mundet, Antoni
|
|
|
|
Generation of new cytotoxic human ribonuclease variants directed to the nucleus |
Vert Company, Anna
; Castro Gallegos, Jessica
; Ruiz MartĂnez, Santiago
; Tubert Juhé, Pere
; Escribano, Diego
; RibĂł i Panosa, Marc
; Vilanova i Brugués, Maria
; Benito i Mundet, Antoni
|
|
|
2011 |
A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation |
Castro Gallegos, Jessica
; RibĂł i Panosa, Marc
; Navarro, Susanna
; Nogués, Maria Victòria
; Vilanova i Brugués, Maria
; Benito i Mundet, Antoni
|
|
|
|
A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation |
Castro Gallegos, Jessica
; RibĂł i Panosa, Marc
; Navarro, Susanna
; Nogués, Maria Victòria
; Vilanova i Brugués, Maria
; Benito i Mundet, Antoni
|
|
|
|
A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation |
Castro Gallegos, Jessica
; RibĂł i Panosa, Marc
; Navarro, Susanna
; Nogués, Maria Victòria
; Vilanova i Brugués, Maria
; Benito i Mundet, Antoni
|
|
|
2018 June 1 |
A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation |
|
|
|
2018 June 5 |
A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation |
Castro Gallegos, Jessica
; RibĂł i Panosa, Marc
; Navarro, Susanna
; Nogués, Maria Victòria
; Vilanova i Brugués, Maria
; Benito i Mundet, Antoni
|
|
|
2016 November |
Impact of BRCA1/2 somatic mutations in patients with pancreatic cancer in Girona: a population-based study |
Huarachi Berne, Nadia
|
|
|
|
Impact of BRCA1/2 somatic mutations in patients with pancreatic cancer in Girona: a population-based study |
GarcĂa Velasco, Adelaida
; Huarachi Berne, Nadia
|
|
|
2020 November |
Influence of the toxicity from induction treatment with immunotherapy in the surgical rescue of patients with NSCLC in N2: a multicenter cohort prospective study |
AzemĂ Rovira, Maria
|
|
|
2017 January |
Intracorporeal vs. extracorporeal anastomosis in laparoscopic right hemicolectomy for cancer |
Aramburu Munoa, Alba
|
|
|
|
Intracorporeal vs. extracorporeal anastomosis in laparoscopic right hemicolectomy for cancer |
Aramburu Munoa, Alba
|
|
|
2012 April |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
CufĂ González, SĂlvia
; Corominas Faja, Bruna
; Vázquez MartĂn, Alejandro
; Oliveras FerrarĂłs, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
|
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
CufĂ González, SĂlvia
; Corominas Faja, Bruna
; Vázquez MartĂn, Alejandro
; Oliveras FerrarĂłs, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
|
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
CufĂ González, SĂlvia
; Corominas Faja, Bruna
; Vázquez MartĂn, Alejandro
; Oliveras FerrarĂłs, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
2018 June 1 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
|
|
|
2018 June 5 |
Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts |
CufĂ González, SĂlvia
; Corominas Faja, Bruna
; Vázquez MartĂn, Alejandro
; Oliveras FerrarĂłs, Cristina
; Dorca Ribugent, Joan
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Menéndez Menéndez, Javier Abel
|
|
|
2021 |
Necessitats de les dones amb cĂ ncer de mama finalitzada la fase aguda del tractament: projecte de recerca qualitatiu |
Garcia Canovas, Marta
|
|
|
2011 |
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; CufĂ González, SĂlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega GutiĂ©rrez, SĂlvia
; BenhamĂş, Bellinda
; LĂłpez RodrĂguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
|
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; CufĂ González, SĂlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega GutiĂ©rrez, SĂlvia
; BenhamĂş, Bellinda
; LĂłpez RodrĂguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
|
|
|
A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines |
Puig i Miquel, Teresa
; Aguilar, Helena
; CufĂ González, SĂlvia
; Oliveras, Glòria
; Turrado, Carlos
; Ortega GutiĂ©rrez, SĂlvia
; BenhamĂş, Bellinda
; LĂłpez RodrĂguez, Maria Luz
; Urruticoechea, Ander
; Colomer, Ramon
|
